555 related items for PubMed ID: 30360670
1. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
Siligato R, Cernaro V, Nardi C, De Gregorio F, Gembillo G, Costantino G, Conti G, Buemi M, Santoro D.
Expert Opin Investig Drugs; 2018 Nov; 27(11):839-879. PubMed ID: 30360670
[Abstract] [Full Text] [Related]
2. Minimal change disease and focal segmental glomerulosclerosis in adults: response to steroids and risk of renal failure.
Moura LR, Franco MF, Kirsztajn GM.
J Bras Nefrol; 2015 Nov; 37(4):475-80. PubMed ID: 26648497
[Abstract] [Full Text] [Related]
3. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A, Roshan A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Sibley M, Mammen C, Matsell DG, Pediatric Nephrology Clinical Pathway Development Team.
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[Abstract] [Full Text] [Related]
4. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA.
Pediatr Nephrol; 2018 Oct; 33(10):1773-1780. PubMed ID: 29982878
[Abstract] [Full Text] [Related]
5. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.
Hansrivijit P, Cheungpasitporn W, Thongprayoon C, Ghahramani N.
BMC Nephrol; 2020 Apr 15; 21(1):134. PubMed ID: 32293308
[Abstract] [Full Text] [Related]
6. Idiopathic nephrotic syndrome in Syrian children: clinicopathological spectrum, treatment, and outcomes.
Wannous H.
Pediatr Nephrol; 2024 Aug 15; 39(8):2413-2422. PubMed ID: 38587559
[Abstract] [Full Text] [Related]
7. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study.
Lan L, Lin Y, Yu B, Wang Y, Pan H, Wang H, Lou X, Lang X, Zhang Q, Jin L, Yang Y, Xiao L, Chen J, Han F.
Am J Nephrol; 2024 Aug 15; 55(1):25-36. PubMed ID: 37963441
[Abstract] [Full Text] [Related]
8. [Minimal change disease and focal segmental glomerulosclerosis].
Müller-Deile J, Schenk H, Schiffer M.
Internist (Berl); 2019 May 15; 60(5):450-457. PubMed ID: 30887070
[Abstract] [Full Text] [Related]
9. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
Peters HP, van de Kar NC, Wetzels JF.
Neth J Med; 2008 Nov 15; 66(10):408-15. PubMed ID: 19011266
[Abstract] [Full Text] [Related]
10. Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases.
Kronbichler A, König P, Busch M, Wolf G, Mayer G, Rudnicki M.
Wien Klin Wochenschr; 2013 Jun 15; 125(11-12):328-33. PubMed ID: 23624956
[Abstract] [Full Text] [Related]
11. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
Clin Exp Nephrol; 2020 Jun 15; 24(6):526-540. PubMed ID: 32146646
[Abstract] [Full Text] [Related]
12. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis.
Kronbichler A, Bruchfeld A.
Nephron Clin Pract; 2014 Jun 15; 128(3-4):277-82. PubMed ID: 25401966
[Abstract] [Full Text] [Related]
13. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
Clin Exp Nephrol; 2018 Dec 15; 22(6):1266-1280. PubMed ID: 29679356
[Abstract] [Full Text] [Related]
14. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, Hrušková Z, Jeyabalan A, Karras A, King C, Kohli HS, Maas R, Mayer G, Moiseev S, Muto M, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Segelmark M, Tesař V, Wetzels J, Willcocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A, RITERM study group.
Autoimmun Rev; 2020 Nov 15; 19(11):102671. PubMed ID: 32942039
[Abstract] [Full Text] [Related]
15. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
Clin Nephrol; 1995 Jun 15; 43(6):375-81. PubMed ID: 7554521
[Abstract] [Full Text] [Related]
16. Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome.
Chehade H, Parvex P, Poncet A, Werner D, Mosig D, Cachat F, Girardin E.
Pediatr Nephrol; 2013 Dec 15; 28(12):2299-306. PubMed ID: 23949592
[Abstract] [Full Text] [Related]
17. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD.
Kidney Int; 2004 May 15; 65(5):1690-702. PubMed ID: 15086908
[Abstract] [Full Text] [Related]
18. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
Kolonko A, Piecha G, Więcek A.
Transplant Proc; 2016 Nov 15; 48(9):3092-3094. PubMed ID: 27932154
[Abstract] [Full Text] [Related]
19. Therapeutic Response and Long-Term Renal Outcomes in Childhood Idiopathic Steroid-Resistant Nephrotic Syndrome: A Single-Center Study.
Jung J, Lee JH, Park YS.
Nephron; 2022 Nov 15; 146(4):327-334. PubMed ID: 34929692
[Abstract] [Full Text] [Related]
20. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
Kisner T, Burst V, Teschner S, Benzing T, Kurschat CE.
Nephron Clin Pract; 2012 Nov 15; 120(2):c79-85. PubMed ID: 22286071
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
